These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1997187)
1. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro. Danforth DN; Sgagias MK Cancer Res; 1991 Mar; 51(5):1488-93. PubMed ID: 1997187 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Danforth DN; Sgagias MK Cancer Res; 1993 Apr; 53(7):1538-45. PubMed ID: 8453620 [TBL] [Abstract][Full Text] [Related]
3. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S; Krishnan AV; Feldman D Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825 [TBL] [Abstract][Full Text] [Related]
4. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855 [TBL] [Abstract][Full Text] [Related]
5. Estradiol induction of retinoic acid receptors in human breast cancer cells. Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Toi M; Bicknell R; Harris AL Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401 [TBL] [Abstract][Full Text] [Related]
7. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture. Jain PT; Pento JT; Magarian RA Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114 [TBL] [Abstract][Full Text] [Related]
8. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799 [TBL] [Abstract][Full Text] [Related]
9. Selective regulation of steroid receptor expression in MCF-7 breast cancer cells by a novel member of the heregulin family. Mueller H; Kueng W; Schoumacher F; Herzer S; Eppenberger U Biochem Biophys Res Commun; 1995 Dec; 217(3):1271-8. PubMed ID: 8554586 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Gooch JL; Lee AV; Yee D Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635 [TBL] [Abstract][Full Text] [Related]
11. Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth. Cormier EM; Wolf MF; Jordan VC Cancer Res; 1989 Feb; 49(3):576-80. PubMed ID: 2783381 [TBL] [Abstract][Full Text] [Related]
12. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen. Morrissey JJ; Raney S Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
14. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Herman ME; Katzenellenbogen BS Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416 [TBL] [Abstract][Full Text] [Related]
15. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells. Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803 [TBL] [Abstract][Full Text] [Related]
17. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768 [TBL] [Abstract][Full Text] [Related]
18. Effect of alpha-interferon, 17 beta-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells. Bezwoda WR; Meyer K Cancer Res; 1990 Sep; 50(17):5387-91. PubMed ID: 2386944 [TBL] [Abstract][Full Text] [Related]
19. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Reddel RR; Sutherland RL Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038 [TBL] [Abstract][Full Text] [Related]
20. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA; Lippman ME; Katzenellenbogen BS Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]